Aquestive Therapeutics Inc (AQST) — Cash Flow Reinvestment Rate
Aquestive Therapeutics Inc (AQST) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting $4.00K (capex $2.00K plus investments $-2.00K) from operating cash flow of $8.82 Million. See Aquestive Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aquestive Therapeutics Inc Cash Flow Reinvestment Rate (2017–2017)
Historical reinvestment intensity for Aquestive Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Aquestive Therapeutics Inc.
Annual Cash Flow Reinvestment Rate for Aquestive Therapeutics Inc (2017–2017)
Year-by-year capital reinvestment analysis for Aquestive Therapeutics Inc. See Aquestive Therapeutics Inc (AQST) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2017 | 0.71x | $4.14 Million | $5.82 Million | $2.07 Million | — |